These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3542493)

  • 1. Ethamsylate reduces immunoreactive prostacyclin metabolite in low birthweight infants with respiratory distress syndrome.
    Rennie JM; Doyle J; Cooke RW
    Early Hum Dev; 1986 Dec; 14(3-4):239-44. PubMed ID: 3542493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicentre trial of ethamsylate for prevention of periventricular haemorrhage in very low birthweight infants.
    Benson JW; Drayton MR; Hayward C; Murphy JF; Osborne JP; Rennie JM; Schulte JF; Speidel BD; Cooke RW
    Lancet; 1986 Dec; 2(8519):1297-300. PubMed ID: 2878174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethamsylate reduces the incidence of periventricular haemorrhage in very low birth-weight babies.
    Morgan ME; Benson JW; Cooke RW
    Lancet; 1981 Oct; 2(8251):830-1. PubMed ID: 6116952
    [No Abstract]   [Full Text] [Related]  

  • 4. Prophylactic ethamsylate for periventricular haemorrhage.
    Cooke RW; Morgan ME
    Arch Dis Child; 1984 Jan; 59(1):82-3. PubMed ID: 6696506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated levels of immunoreactive prostacyclin metabolite in babies who develop intraventricular haemorrhage.
    Rennie JM; Doyle J; Cooke RW
    Acta Paediatr Scand; 1987 Jan; 76(1):19-23. PubMed ID: 3564999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of immunoreactive prostacyclin metabolite after paralysis in ventilated preterm infants.
    Rennie JM; Doyle J; Cooke RW
    Early Hum Dev; 1986 Feb; 13(1):75-80. PubMed ID: 3754206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dynamics of prostacyclin level in low-birth-weight infants with respiratory distress syndrome].
    Suchkova VN; V''iaskova MG; Zybkina AG; Kucherenko AG
    Gematol Transfuziol; 1992; 37(9-10):33-5. PubMed ID: 1490571
    [No Abstract]   [Full Text] [Related]  

  • 8. Ethamsylate for the prevention of morbidity and mortality in preterm or very low birth weight infants.
    Hunt R; Hey E
    Cochrane Database Syst Rev; 2010 Jan; (1):CD004343. PubMed ID: 20091562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic ethamsylate for periventricular haemorrhage.
    Dubowitz LM; Whitelaw A
    Arch Dis Child; 1984 May; 59(5):489-90. PubMed ID: 6732284
    [No Abstract]   [Full Text] [Related]  

  • 10. Intraventricular hemorrhage of the preterm neonate: prevention studies.
    Ment LR; Ehrenkranz RA; Duncan CC
    Semin Perinatol; 1988 Oct; 12(4):359-72. PubMed ID: 3065945
    [No Abstract]   [Full Text] [Related]  

  • 11. Ethamsylate in the prevention of periventricular-intraventricular hemorrhage in premature infants.
    Chen JY
    J Formos Med Assoc; 1993 Oct; 92(10):889-93. PubMed ID: 7908570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of ethamsylate on neonatal mortality in preterm infants.
    Erdem G; Yurdakök M; Tekinalp G; Hiçsönmez G
    Turk J Pediatr; 1988; 30(2):93-7. PubMed ID: 3242186
    [No Abstract]   [Full Text] [Related]  

  • 13. Intrapartum ethamsylate.
    Harrison RF; Matthews T
    Lancet; 1984 Aug; 2(8397):296. PubMed ID: 6146855
    [No Abstract]   [Full Text] [Related]  

  • 14. Operative blood loss and the frequency of haemorrhage associated with adenotonsillectomy in children: a double-blind trial of ethamsylate.
    Arora YR; Manford ML
    Br J Anaesth; 1979 Jun; 51(6):557-61. PubMed ID: 380611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of artificial ventilation on the level of the prostacyclin metabolite 6-ketoprostaglandin F1 alpha in the plasma of newborn infants].
    Szczapa J; Chwalisz K; Rychlik K
    Ginekol Pol; 1987 Mar; 58(3):156-60. PubMed ID: 3653733
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostacyclin concentrations and transitional circulation in preterm infants requiring mechanical ventilation.
    Kluckow M; Evans N; Leslie G; Rowe J
    Arch Dis Child Fetal Neonatal Ed; 1999 Jan; 80(1):F34-7. PubMed ID: 10325809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethamsylate in the treatment of climacteric flushing.
    Harrison RF
    Maturitas; 1981 Mar; 3(1):31-7. PubMed ID: 6789032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased plasma immunoreactive 6-keto-prostaglandin F1 alpha levels in newborns with idiopathic respiratory distress syndrome.
    Kääpä P; Koivisto M; Viinikka L; Ylikorkala O
    Pediatr Res; 1982 Oct; 16(10):827-9. PubMed ID: 6897290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of symptomatic patent ductus arteriosus with ethamsylate in babies treated with exogenous surfactant.
    Amato M; Hüppi P; Markus D
    J Perinatol; 1993; 13(1):2-7. PubMed ID: 8445442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental outcome of the use of etamsylate for prevention of periventricular haemorrhage in a randomised controlled trial.
    Schulte J; Osborne J; Benson JW; Cooke R; Drayton M; Murphy J; Rennie J; Speidel B
    Arch Dis Child Fetal Neonatal Ed; 2005 Jan; 90(1):F31-5. PubMed ID: 15613570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.